Concepedia
Statistics
Publications
24
Citations
1.5K
H-Index
19
Active since
2003
Affiliations
AstraZeneca (Sweden)(Current)
Vanderbilt University
Virginia Tech
AstraZeneca (United States)
UCB Pharma (Belgium)
Emre M. Isin is an author at AstraZeneca (Sweden) specializing in biochemistry, medicine, and natural sciences.
Top concepts
BiochemistryMedicinePharmacologyNatural SciencesMetabolomicsDrug DiscoveryMolecular BiologyMetabolismToxicologyRedox Biology
Publications per year
2003–2022
Use of Radiolabeled Compounds in Drug Metabolism and Pharmacokinetic Studies
Emre M. Isin, Charles S. Elmore, Göran N. Nilsson et al. · Chemical Research in Toxicology · 2012 · 284 citations
In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs
Richard A. Thompson, Emre M. Isin, Yan Li et al. · Chemical Research in Toxicology · 2012 · 212 citations
Immunology, Pharmacotherapy, Iadrs Arise +21
Engineering highly functional thermostable proteins using ancestral sequence reconstruction
Yosephin Gumulya, Jong‐Min Baek, Shun Jie Wun et al. · Nature Catalysis · 2018 · 187 citations
Structural Bioinformatics, Protein Folding, Natural Sciences +7
Kinetics and Thermodynamics of Ligand Binding by Cytochrome P450 3A4
Emre M. Isin, F. Peter Guengerich · Journal of Biological Chemistry · 2006 · 144 citations · Full text
Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development
Richard A. Thompson, Emre M. Isin, Yan Li et al. · Chemico-Biological Interactions · 2010 · 102 citations
Risk Assessment, Reactive Metabolites, Predictive Toxicology +10
1–5 of 24